| Literature DB >> 31780857 |
Julia Salvan da Rosa1, Marcus Vinicius Pereira Dos Santos Nascimento1, Eduardo Benedetti Parisotto2, Tamires Cardoso Lima3, José Roberto Santin4, Maique Weber Biavatti3, Ariane Zamoner2, Eduardo Monguilhott Dalmarco1, Tânia Silvia Fröde1.
Abstract
The literature shows that phenolic compounds possess important antioxidant and anti-inflammatory activities; however, the mechanism underlying these effects is not elucidated yet. The genus Calea is used in folk medicine to treat rheumatism, respiratory diseases, and digestive problems. In this context, some phenolic compounds were isolated with high purity from Calea uniflora Less. and identified as noreugenin (NRG) and α-hydroxy-butein (AH-BU). The aim of this study was to analyze the effect of these compounds on cell viability, the activity of myeloperoxidase (MPO), and apoptosis of mouse neutrophils using ex vivo tests. Furthermore, the effect of these compounds on the cytokines, interleukin 1 beta (IL-1β), interleukin 17A (IL-17A), and interleukin 10 (IL-10), and oxidative stress was investigated by analyzing lipid peroxidation (the concentration of thiobarbituric acid reactive substances (TBARS)) and activities of antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT), and glutathione S-transferase (GST), using a murine model of neutrophilic inflammation. The NRG and AH-BU reduce MPO activity and increase neutrophil apoptosis (p < 0.05). These compounds reduced the generation of oxygen reactive species and IL-1β and IL-17A levels but increased IL-10 levels (p < 0.05). This study demonstrated that NRG and AH-BU show a significant anti-inflammatory effect by inhibiting the MPO activity and increasing neutrophil apoptosis in primary cultures of mouse neutrophils. These effects were at least partially associated with blocking reactive species generation, inhibiting IL-1β and IL-17A, and increasing IL-10 levels.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31780857 PMCID: PMC6875232 DOI: 10.1155/2019/1468502
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Chemical structure of isolated compounds: noreugenin (a) and α-hydroxy-butein (b) from C. uniflora Less.
Figure 2Effect of noreugenin (a) and α-hydroxy-butein (b) on cell viability of murine neutrophils. Vehicle = the isolated neutrophils treated only with sterile phosphate-buffered saline (PBS, pH 7.6). LPS = cells treated with LPS (5 μg/mL) only. Noreugenin = cells treated with noreugenin (1-100 μM)+LPS (5 μg/mL). α-Hydroxy-butein = cells treated with α-hydroxy-butein (1-100 μM)+LPS (5 μg/mL). Each group represents the mean ± S.E.M. of experiments conducted in triplicate from three to six animals. ∗∗p < 0.01 compared to the control group (Control); ANOVA/Newman–Keuls test.
Effects of noreugenin (NRG) or α-hydroxy-butein (AH-BU) on myeloperoxidase activity of the neutrophils obtained from fluid leakage from the mouse peritoneal cavity 4 h after an intraperitoneal injection of oyster glycogen solution.
| Groups | Concentrations ( | MPO (mU/mL) (% of inhibition) |
|---|---|---|
| Control | 371.10 ± 3.30 | |
| LPS | 437.80 ± 5.80 | |
|
| ||
| Noreugenin | 1 | 423.10 ± 4.21 |
| 2.5 | 417.30 ± 7.53 | |
| 5 | 391.90 ± 10.76(10.47±2.46%)∗∗ | |
| 10 | 373.90 ± 11.48(14.60±2.62%)∗∗ | |
| 50 | 369.20 ± 5.32(15.68±1.21%)∗∗ | |
|
| ||
|
| 1 | 418.40 ± 6.92 |
| 2.5 | 418.40 ± 6.88 | |
| 5 | 379.90 ± 7.82(13.23±1.79%)∗∗ | |
| 10 | 371.00 ± 7.50(15.26±1.71%)∗∗ | |
| 50 | 365.80 ± 3.15(16.46±0.72%)∗∗ | |
MPO: myeloperoxidase; LPS: lipopolysaccharide. Cells were pretreated with different concentrations of noreugenin (NRG: 1–50 μM) or α-hydroxy-butein (AH-BU: 1–50 μM) for 0.5 h and then stimulated with LPS (5 μg/mL) for 18 h. Control = cells treated with sterile phosphate-buffered saline (PBS, pH 7.6) only. LPS = cells treated with LPS (5 μg/mL) only. Each group represents the mean ± S.E.M. of experiments conducted in triplicate from three to six animals. ∗∗p < 0.01 compared to the positive control group (LPS); ANOVA/Newman–Keuls test.
Figure 3Effect of noreugenin or α-hydroxy-butein on neutrophilic apoptosis in carrageenan-induced inflammation in the mouse model of pleurisy. Neutrophils were characterized in flow cytometry by expression of Ly6G and CD11b and absence of F4/80 in their surface. Basal = cells treated with sterile phosphate-buffered saline (PBS, pH 7.6) only. LPS = cells treated with LPS (5 μg/mL) only. NRG = cells treated with noreugenin (5 μM)+LPS (5 μg/mL). AH-BU = cells treated with α-hydroxy-butein (5 μM)+LPS (5 μg/mL). Bars represent the mean ± S.E.M. of experiments conducted in triplicate from three to six animals. The values in brackets represent the percentages of inhibition. ∗p < 0.05 and ∗∗p < 0.01 compared to the positive control group (LPS); ANOVA/Newman–Keuls test.
Figure 4Effect of noreugenin or α-hydroxy-butein upon IL-1β (a), IL-17A (b), and IL-10 (c) levels in carrageenan-induced inflammation in the mouse model of pleurisy. Control = animals treated with saline solution (NaCl 0.9%) only. Cg = animals treated with carrageenan (1%) only. Dex = animals pretreated with dexamethasone (0.5 mg/kg, i.p.). NRG = noreugenin (5 mg/kg, i.p.). AH-BU = α-hydroxy-butein (2.5 mg/kg, i.p.). Bars represent the mean ± S.E.M. of 5 animals. The values in brackets represent the percentages of inhibition. ∗p < 0.05 and ∗∗p < 0.01 compared to the positive control group (Cg); ANOVA/Newman–Keuls test.
Effects of noreugenin (NRG) and α-hydroxy-butein (AH-BU) on antioxidant enzyme activities and TBARS concentration in carrageenan-induced inflammation in the mouse model of pleurisy.
| Groups/dose (mg/kg) | CAT (mmol/min/mL) (% of inhibition) | SOD (USOD/mL) (% of inhibition) | GST ( | TBARS (mmol/mL) (% of inhibition) |
|---|---|---|---|---|
| Sala | 10.91 ± 1.20 | 31.45 ± 3.73 | 6.90 ± 1.10 | 2.81 ± 0.21 |
| Cga | 31.61 ± 4.22 | 63.75 ± 3.19 | 16.36 ± 0.59 | 10.64 ± 0.58 |
| Dex (0.5)b | 14.05 ± 0.63(55.54±1.99)∗∗ | 40.90 ± 3.63(35.84 ± 5.70)∗ | 9.57 ± 0.74(41.49±4.52)∗∗ | 4.13 ± 0.85(61.18±7.96)∗∗ |
| NRG (5)b | 12.04 ± 1.23(61.93±3.88)∗∗ | 39.55 ± 4.09(37.96 ± 6.42)∗ | 4.23 ± 0.29(74.15±1.80)∗∗ | 5.88 ± 0.96(44.72±9.02)∗∗ |
| AH-BU (2.5)b | 13.23 ± 2.13(58.16±6.74)∗∗ | 26.43 ± 5.68(58.55±8.91)∗∗ | 5.31 ± 0.94(67.56±5.74)∗∗ | 6.00 ± 0.57(43.61 ± 5.36)∗ |
CAT: catalase; SOD: superoxide dismutase; GST: glutathione S-transferase; TBARS: thiobarbituric acid reactive substances. Noreugenin (NRG: 5 mg/kg) and α-hydroxy-butein (AH-BU: 2.5 mg/kg) administered 0.5 h before pleurisy induction by carrageenan (1%). Sal = animals treated with sterile saline solution (NaCl 0.9%) only. Cg = animals treated with carrageenan (1%) only. Dex = animals pretreated with dexamethasone (0.5 mg/kg). aAdministered by intrapleural injection (i.pl.). bAdministered by intraperitoneal route (i.p.). Each group represents the mean ± S.E.M. of 5 animals. ∗p < 0.05 and ∗∗p < 0.01 compared to the positive control group (Cg); ANOVA/Newman–Keuls test.